Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 38, n° 6
pages 950-954 (juin 1998)
Doi : 10.1016/S0190-9622(98)70158-6
accepted : 7 Mars 1998
Analysis of vascularity of human neurofibromas
 

Jack L. Arbiser, MD, PhD a, b, Evelyn Flynn b, Raymond L. Barnhill, MD c
a Department of Dermatology, Harvard Medical School Boston, Massachusetts 
b Department of Surgery, Childrens Hospital Boston, Massachusetts 
c Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School. Boston, Massachusetts 

Abstract

Background: A common misperception is that the vascularity of a tumor can be determined by its gross appearance. Neurofibromas are grossly white in appearance. The degree of vascularity of neurofibromas has not been determined. Objective: The purpose of this study was to determine the extent of neovascularization of neurofibromas. Methods: Neurofibromas from patients with neurofibromatosis-1 or spontaneous neurofibromas were stained with antibodies against von Willebrand factor (factor VIII–related antigen) and vascular endothelial growth factor (VEGF). Results: Neurofibromas, both spontaneous and congenital, exhibit a high degree of vascularity. In addition, perivascular cells in neurofibromas stain with antibodies to VEGF, an angiogenic factor. Conclusion: Neurofibromas, despite their gross appearance, are highly vascular. Their vascularity may be mediated, in part, through the angiogenic factor VEGF. (J Am Acad Dermatol 1998;39:950-4.)

The full text of this article is available in PDF format.

 Supported in part by a Howard Hughes Postdoctoral Fellowship (to J. L. A.) and a grant from the Society for Pediatric Dermatology (to J. L. A.), the KAO Corporation Thomas B. Fitzpatrick Research Award (to J. L. A.), National Institutes of Health grant RO3AR44947 (to J. L. A.), and a Dermatology Foundation Clinical Career Development Award (to J. L. A.).
 Reprint requests: Jack L. Arbiser, MD, PhD, Emory University School of Medicine, Dept. of Dermatology, WMB 5th Floor, 1639 Pierce Dr., Atlanta, GA 30322.
 0190-9622/98/$5.00 + 0   16/1/90113



© 1998  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline